206 related articles for article (PubMed ID: 10408492)
1. Venous thromboembolism among new users of different oral contraceptives.
Herings RM; Urquhart J; Leufkens HG
Lancet; 1999 Jul; 354(9173):127-8. PubMed ID: 10408492
[TBL] [Abstract][Full Text] [Related]
2. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
3. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
[TBL] [Abstract][Full Text] [Related]
4. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
Rosing J; Middeldorp S; Curvers J; Christella M; Thomassen LG; Nicolaes GA; Meijers JC; Bouma BN; Büller HR; Prins MH; Tans G
Lancet; 1999 Dec; 354(9195):2036-40. PubMed ID: 10636369
[TBL] [Abstract][Full Text] [Related]
5. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
[TBL] [Abstract][Full Text] [Related]
6. The risks of venous thromboembolic disease among German women using oral contraceptives: a database study.
Farmer RD; Todd JC; Lewis MA; MacRae KD; Williams TJ
Contraception; 1998 Feb; 57(2):67-70. PubMed ID: 9589831
[TBL] [Abstract][Full Text] [Related]
7. First-time use of newer oral contraceptives and the risk of venous thromboembolism.
Suissa S; Blais L; Spitzer WO; Cusson J; Lewis M; Heinemann L
Contraception; 1997 Sep; 56(3):141-6. PubMed ID: 9347203
[TBL] [Abstract][Full Text] [Related]
8. Smoking and use of oral contraceptives: impact on thrombotic diseases.
Lidegaard O
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
[TBL] [Abstract][Full Text] [Related]
9. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts?
Contracept Rep; 1996 Apr; 7(1):3-6. PubMed ID: 12320047
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany.
Farmer RD; Lawrenson RA
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S78-86. PubMed ID: 9753314
[TBL] [Abstract][Full Text] [Related]
12. Effects on hemostatic variables of desogestrel- and gestodene-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: a review.
Winkler UH
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S51-61. PubMed ID: 9753311
[TBL] [Abstract][Full Text] [Related]
13. The differential risk of oral contraceptives: the impact of full exposure history.
Lewis MA; MacRae KD; Kühl-Habichl D; Bruppacher R; Heinemann LA; Spitzer WO
Hum Reprod; 1999 Jun; 14(6):1493-9. PubMed ID: 10359554
[TBL] [Abstract][Full Text] [Related]
14. Oral contraception and venous thromboembolism. A New Zealand perspective.
Roke C
Drug Saf; 1997 Feb; 16(2):79-87. PubMed ID: 9067120
[TBL] [Abstract][Full Text] [Related]
15. Thrombotic diseases in young women and the influence of oral contraceptives.
Lidegaard O
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S62-7. PubMed ID: 9753312
[TBL] [Abstract][Full Text] [Related]
16. 2 methods for prescribing third-generation OCs.
Contracept Technol Update; 1997 Dec; 18(12):148-9. PubMed ID: 12348220
[TBL] [Abstract][Full Text] [Related]
17. Third-generation oral contraceptives: how risky?
Weiss N
Lancet; 1995 Dec; 346(8990):1570. PubMed ID: 7500743
[TBL] [Abstract][Full Text] [Related]
18. Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives.
Schwingl PJ; Shelton J
Contraception; 1997 Mar; 55(3):125-9. PubMed ID: 9114999
[TBL] [Abstract][Full Text] [Related]
19. Modern oral contraceptives and cardiovascular disease.
Rosenberg L; Palmer JR; Sands MI; Grimes D; Bergman U; Daling J; Mills A
Am J Obstet Gynecol; 1997 Sep; 177(3):707-15. PubMed ID: 9322646
[TBL] [Abstract][Full Text] [Related]
20. Increased number of induced abortions in Norway after media coverage of adverse vascular events from the use of third-generation oral contraceptives.
Skjeldestad FE
Contraception; 1997 Jan; 55(1):11-4. PubMed ID: 9013055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]